<DOC>
	<DOCNO>NCT00164788</DOCNO>
	<brief_summary>The investigator hypothesize high dose esomeprazole 80mg give bolus , follow 8mg/h would render gastric pH near neutral pH control esomeprazole give high dose either intravenous orally identical .</brief_summary>
	<brief_title>A Comparison Gastric pH Control With High Dose Intravenous Oral Esomeprazole</brief_title>
	<detailed_description>Bleeding peptic ulcer common life threaten condition . Endoscopic therapy become mainstay control bleeding . Recurrent bleed endoscopic control occur 20 % patient high associate mortality . We previously demonstrate adjunct use high dose proton pump inhibitor reduces risk recurrent bleed thereby improves patient ' outcome [ Lau JY N Engl J Med 2000 ] . The new PPI , esomeprazole , S-isomer omeprazole . Esomeprazole effective gastric acid control measure basal pentagastrin acid output compare omeprazole . Esomeprazole give orally low dose achieves similar gastric control intravenous esomeprazole . The gastric pH high dose esomeprazole give either orally intravenously measure among Hong Kong Chinese . If high dose oral esomeprazole achieves similar pH control near gastric neutrality , oral regime use place intravenous formulation . This represent significant convenience dose cost saving .</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Gastrointestinal Hemorrhage</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<criteria>Patients admit diagnosis upper gastrointestinal bleeding age 18 80 Endoscopic confirmation bleed duodenal gastric ulcer endoscopic control obtain Absence H. pylorus infection Informed write consent Known incompatibility study drug ; Known incompatibility hypersensitivity proton pump inhibitor H. pylorus infection Recent H2RA PPI use ( within last 4 week ) Concomitant use medication may interfere gastric acid secretion motility ( e.g . anticholinergic , metoclopramide , domperidone ) Pregnancy lactation ; Noncompliance e.g . mental subordination Nasopharyngeal oropharyngeal pathology would prevent passage nasal catheter Significant liver disease PPI metabolize cytochrome P450 system Previous gastric surgery Chronic Aspirin user Presence esophageal/ gastric varix Moribund patient , terminal malignancy &amp; patient severe renal disease Patient unable give write consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>24 hour pH monitoring</keyword>
</DOC>